Clinical Trial Update: Multi-omics Studies of Primary Aldosteronism

View source ↗

Summary

A clinical trial exploring multi-omics approaches to primary aldosteronism, currently in recruiting status at Peking University First Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Snippet

Sponsor: Peking University First Hospital | Conditions: Primary Aldosteronism | Status: RECRUITING